Timing of Noninvasive Ventilation Initiation for Chronic Hypercapnic Respiratory Failure of COPD [0.03%]
慢性阻塞性肺疾病所致慢性高碳酸血症性呼吸衰竭无创通气的起始时机研究
Umur Hatipoğlu,Jason Dean,Loutfi Sami Aboussouan
Umur Hatipoğlu
Call to Action: How Can We Promote the Development of New Pharmacologic Treatments in Chronic Obstructive Pulmonary Disease? [0.03%]
呼吁行动：我们如何才能促进慢性阻塞性肺疾病的新型药理学治疗的发展？
Daniel C Belz,Nirupama Putcha,Patricia Alupo et al.
Daniel C Belz et al.
Using an Electrocautery Snare in Semirigid Thoracoscopic Biopsy for the Diagnosis of Malignant Pleural Mesothelioma [0.03%]
电外科套扎器在恶性胸膜间皮瘤诊断中的应用：半硬质胸腔镜活检中的使用体验报告
Rao Du,Kaige Wang,Hui Mao et al.
Rao Du et al.
Exercise Limitation in Pulmonary Hypertension - Physiological Insights into the 6-Minute Walk Test [0.03%]
肺动脉高压运动限制的研究——六分钟步行试验的生理学见解
Nils Kremer,Simon Schaefer,Athiththan Yogeswaran et al.
Nils Kremer et al.
Shaurya Taran,Robert D Stevens
Shaurya Taran
Michael Marll,Colin Swenson
Michael Marll
The Arousal Threshold: The "Weakest Link" in Obstructive Sleep Apnea Pathogenesis? [0.03%]
觉醒阈值：阻塞性睡眠呼吸暂停发病机制的“薄弱环节”？
Simon A Joosten,Bradley A Edwards,Shane A Landry
Simon A Joosten
Michael C Sklar,Duminda N Wijeysundera
Michael C Sklar
Efficacy and Safety of Admilparant, an LPA1 Antagonist in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial [0.03%]
氨甲磺酸阿德米拉普坦治疗肺纤维化的疗效和安全性：一项二期随机临床试验
Tamera J Corte,Juergen Behr,Vincent Cottin et al.
Tamera J Corte et al.
Rationale: Idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) have high morbidity and mortality; thus, novel treatments are needed. ...
A Comment about Studying the Health Effects of Smoke Produced by Prescribed Fire [0.03%]
关于研究处方燃烧烟雾健康影响的评论
Laura C Myers,Franziska Rosser
Laura C Myers